1. Adults 19 years of age or older, who have been received at least one dose of PRISTIQ®
for the treatment of Major depressive disorder (MDD).
2. Patients who have been received for the first time after signed the 'data privacy
Patients to whom PRISTIQ® is contraindicated as per the local labeling;
1. Hypersensitivity to desvenlafaxine succinate, venlafaxine hydrochloride or any
excipients in the PRISTIQ® formulation.
2. Serotonin syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders
with PRISTIQ® or Do not use PRISTIQ® within 14 days of stopping an MAOI intended to
treat psychiatric disorders